50 employees
Inhibitex is a clinical-stage biopharmaceutical company that develops treatments for bacterial and viral infections.
1994
$20M
from 3 investors over 3 rounds
Inhibitex raised $20M on February 11, 2002
Investors: Williams Investors Llc, Alliance ventures and Pacific Horizon Ventures